Martin Makary Becomes the 27th FDA Commissioner

Tian Zhang: Best practices for second line treatment in Metastatic Urothelial Carcinoma

How Much Does it Cost to Approve a Drug? EMA vs. FDA Regulations and Timelines

Lisa A. Lacasse: ACS CAN calls on the administration to ensure sustained investment in tobacco control initiatives

U.S. Department of Health and Human Services welcomes Marty Makary as FDA Commissioner and Jay Bhattacharya as NIH Director

FDA welcomes Martin A. Makary as the 27th Commissioner of the U.S. Food and Drug Administration

Maryam S. Yazdy: From FDA to BeiGene – Embracing a New Chapter

Rachel Riechelmann and Guilherme Rossato discussion on treatment options for a patient with a pancreatic NET – Tumor Board Tuesday

AstraZeneca’s Head of US Oncology Mohit Manrao’s statement about FDA approval of NIAGARA regimen

Tislelizumab (Tevimbra): Uses in Cancer, Side Effects, Dosage, Expectations, and More